البلد: أستراليا
اللغة: الإنجليزية
المصدر: APVMA (Australian Pesticides and Veterinary Medicines Authority)
ACETYL GLUCOSAMINE; SODIUM HYALURONATE; PENTOSAN POLYSULFATE SODIUM
CEVA ANIMAL HEALTH PTY LTD
acetyl glucosamine(120mg/mL)+sodium pentosan polysulfate(75mg/mL) + others
PARENTERAL LIQUID/SOLUTION/SUSPENSION
ACETYL GLUCOSAMINE CARBOHYDRATE-GLUCOSE Active 120.0 mg/ml; SODIUM HYALURONATE UNGROUPED Active 3.0 mg/ml; PENTOSAN POLYSULFATE SODIUM MINERAL-SODIUM Active 75.0 mg/ml
20 mL; 6x 20mL
VM - Veterinary Medicine
CEVA ANIMAL HEALTH
MUSCULOSKELETAL SYSTEM
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: HORSE: [INFLAMMATORY JOINT DISEASE]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [INFLAMMATORY JOINT DISEASE]; As an aid in the treatment of non-infectious inflammatory joint disease in horses.See restraints, contraindications and precautions on label.
Registered
2023-07-01
Australian Government Australian Pestiddes and Veterinary Medicines Authority RELEVANT LABEL PARTICULARS (RLPs) (Veterinary Products) Select appropriate: Iii New Product (include all applicable RLPs) OR C Variation (highlight instructions that are being varied). Approval no. of label being varied: Signal heading: Product name: Active constituent/s: Statement of claims: Net contents: Directions for Use Heading: Restraints: Contraindications: Precautions: Side effects: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY NV Pentosan Evolution Injection for Horses 120 mg/mL Acetyl glucosamine 75 mg/mL Pentosan polysulfate sodium RLP 3 mg/mL Sodium hyaluronate Approved As an aid in the treatment of non-infectious inflammatory joint disease in horses. 20 mL [6 x 20 mL] DIRECTIONS FOR USE DO NOT USE in horses that may be used for human consumption. This product is contraindicated for use in horses with clotting defects, traumatic haemorrhage, infection, liver or kidney failure or within 2 days of surgery. This product is contraindicated for use in horses within 24 hours of high stress activities or where physical injury may occur. This product is contraindicated for concurrent treatment with anticoagulant drugs. This product has anticoagulant aciivity. To prevent haemorrhage it is recommended to use a 21 G needle and to press firmly on the site of injection for approximately 1 minute after administration. Safety of this product has not been tested in horses less than two years of age. Safety of this product has not been tested in pregnant, breeding or lactating animals. Use of the product in these animals is not recommended. Safety studies for this product in horses were conducted at up to 3X the recommended dose rate at weekly intervals for up to six weeks. Safety of this product for longer term use has not been tested. Radiographic examination to rule out joint fractures should be conducted prior to treatment. A dose dependent increase in activated partial thromboplastin time (aPTT) was اقرأ الوثيقة كاملة
PRODUCT NAME: NV PENTOSAN EVOLUTION INJECTION FOR HORSES PAGE: 1 OF 5 THIS VERSION ISSUED: AUGUST, 2016 SAFETY DATA SHEET Issued by: Ceva Animal Health Pty Ltd Phone: 02 9652 7000 (office hours) POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER CEVA ANIMAL HEALTH PTY LTD PHONE: 02 9652 7000 (OFFICE HOURS) 11 MOORES RD FAX: 02 9652 7001 GLENORIE NSW 2157 WWW.CEVA.COM.AU CHEMICAL NATURE: Blend of ingredients in saline solution. TRADE NAME: NV PENTOSAN EVOLUTION INJECTION FOR HORSES APVMA CODE: 65881 PRODUCT USE: An aid in the treatment of non-inflammatory joint disease in horses. CREATION DATE: NOVEMBER, 2015 THIS VERSION ISSUED: AUGUST, 2016 and is valid for 5 years from this date. POISONS INFORMATION CENTRE: PHONE 13 1126 FROM ANYWHERE IN AUSTRALIA SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to Australian Dangerous Goods (ADG) Code, IATA or IMDG/IMSBC criteria. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S25, S36. Avoid contact with eyes. Wear suitable protective clothing. SUSMP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good according to Australian Dangerous Goods (ADG) Code, IATA or IMDG/IMSBC criteria. UN NUMBER: None allocated GHS SIGNAL WORD: NONE. NOT HAZARDOUS. PREVENTION P102: Keep out of reach of children. P262: Do not get in eyes, on skin, or on clothing. P281: Use personal protective equipment as required. RESPONSE P352: Wash with plenty of soap and water. P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. P370+P378: Not combustible. Use extinguishing media suited to burning materials. STORAGE P410: Protect from sunlight. P402+P404: Store in a dry place. Store in a closed container. P403+P235: Store in a well-ventilated place. Keep cool (below 25°C). DISPOSAL P501: Dispose of small quantities and اقرأ الوثيقة كاملة